The role of inflammatory cytokines in the pathogenesis of colorectal carcinoma—recent findings and review J Borowczak, K Szczerbowski, M Maniewski, A Kowalewski, ... Biomedicines 10 (7), 1670, 2022 | 33 | 2022 |
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives J Borowczak, K Szczerbowski, N Ahmadi, Ł Szylberg Medical oncology 39 (4), 39, 2022 | 22 | 2022 |
CDK9: therapeutic perspective in HCC therapy J Borowczak, K Szczerbowski, E Stec, D Grzanka, Ł Szylberg Current Cancer Drug Targets 20 (5), 318-324, 2020 | 12 | 2020 |
The prognostic role of CDK9 in bladder cancer J Borowczak, K Szczerbowski, M Maniewski, M Zdrenka, P Słupski, ... Cancers 14 (6), 1492, 2022 | 8 | 2022 |
Refining PD-1/PD-L1 assessment for biomarker-guided immunotherapy: A review M Zdrenka, A Kowalewski, N Ahmadi, RU Sadiqi, Ł Chmura, J Borowczak, ... Biomolecules and Biomedicine 24 (1), 14, 2024 | 3 | 2024 |
TOLLIP protein expression predicts unfavorable outcome in renal cell carcinoma A Kowalewski, D Jaworski, J Borowczak, M Maniewski, K Szczerbowski, ... International Journal of Molecular Sciences 23 (23), 14702, 2022 | 3 | 2022 |
Mechanisms of SARS-CoV-2 Placental Transmission K Gostomczyk, J Borowczak, M Siekielska-Domanowska, K Szczerbowski, ... Archivum Immunologiae et Therapiae Experimentalis 72 (1), 1-10, 2023 | 1 | 2023 |
Diagnostic biopsy does not accurately reflect the PD-L1 expression in triple-negative breast cancer M Zdrenka, A Kowalewski, J Borowczak, J Łysik-Miśkurka, H Andrusewicz, ... Clinical and Experimental Medicine 23 (8), 5121-5127, 2023 | 1 | 2023 |
The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma J Borowczak, K Szczerbowski, M Maniewski, M Zdrenka, P Słupski, ... Clinical and Translational Oncology 25 (3), 830-840, 2023 | 1 | 2023 |
Assessment of immunomodulation and regulation of cell cycle in epithelium and stroma after Cidofovir injection in patients with recurrent respiratory papillomatosis—Pilot study P Solarz, M Bodnar, J Czech, H Mackiewicz–Nartowicz, A Sinkiewicz, ... Journal of Medical Virology 95 (1), e28303, 2023 | 1 | 2023 |
SARS-CoV-2 Infection during Delivery Causes Histopathological Changes in the Placenta J Borowczak, A Gąsiorek-Kwiatkowska, K Szczerbowski, M Maniewski, ... Diseases 12 (7), 142, 2024 | | 2024 |
The role of IL-17 in the pathogenesis and treatment of glioblastoma—an update on the state of the art and future perspectives D Łaszczych, A Czernicka, K Gostomczyk, Ł Szylberg, J Borowczak Medical Oncology 41 (8), 187, 2024 | | 2024 |
Targeting apoptosis in clear cell renal cell carcinoma A Kowalewski, J Borowczak, M Maniewski, K Gostomczyk, D Grzanka, ... Biomedicine & Pharmacotherapy 175, 116805, 2024 | | 2024 |
High MAL2 expression predicts shorter survival in women with triple-negative breast cancer J Borowczak, M Zdrenka, W Socha, K Gostomczyk, K Szczerbowski, ... Clinical and Translational Oncology, 1-10, 2024 | | 2024 |
Lymphovascular Invasion in Gastric Cancer—Important or Unimportant? M Janiczek-Polewska, J Borowczak, Ł Szylberg, I Jagiełło, P Poter, ... Preprints, 2024 | | 2024 |
Atypical Presentation of Bronchogenic Cyst in the Retroperitoneal Space K Gostomczyk, J Borowczak, M Zdrenka, Ł Szylberg Cureus 16 (2), 2024 | | 2024 |
Flow cytometry in the detection of circulating tumor cells in neoplastic effusions K Gostomczyk, E Łukaszewska, J Borowczak, A Bator, M Zdrenka, ... Clinica Chimica Acta 552, 117651, 2024 | | 2024 |
Targeting circulating tumor cells to prevent metastases K Gostomczyk, MDM Marsool, H Tayyab, A Pandey, J Borowczak, ... Human Cell 37 (1), 101-120, 2024 | | 2024 |
Enhanced TOLLIP expression confers poor prognosis in renal cell carcinoma A Kowalewski, D Jaworski, J Borowczak, M Maniewski, P Antosik, ... VIRCHOWS ARCHIV 481 (SUPPL 1), S169-S170, 2022 | | 2022 |
Current Challenges in Targeting Tumor Desmoplasia to Improve the Efficacy of Immunotherapy A Kasperska, J Borowczak, K Szczerbowski, E Stec, N Ahmadi, Ł Szylber Current Cancer Drug Targets 21 (11), 919-931, 2021 | | 2021 |